糖尿病诊疗中的种族与民族不平等:叙述性综述
本文为叙述性综述,综合现有文献阐述糖尿病诊疗中种族与民族不平等的表现与成因。结构性种族主义与健康社会决定因素(如历史红线政策、低收入社区集中贫困)导致少数族裔群体在血糖达标、获取新型降糖药和糖尿病技术方面能力更低,并发症(截肢、失明、终末期肾病)与死亡结局更差。综述同时指出可干预机会,以确保循证诊疗的公平可及。
要点
- 结构性种族主义与健康社会决定因素是糖尿病诊疗不平等的深层根源。
- 少数族裔群体血糖达标、获取新型降糖药与糖尿病技术的能力更低。
- 下游后果为截肢、失明、终末期肾病等并发症及死亡结局更差。
核心结论
- 糖尿病诊疗中的种族与民族不平等根植于健康社会决定因素与结构性种族主义,并导致少数族裔群体并发症与死亡结局更差。
- 综述识别了干预机会,以确保证据为基础的诊疗公平可及。
研究设计与样本
- 叙述性综述,综合当前关于糖尿病诊疗中种族与民族不平等的文献。
主要发现
- 历史红线政策与低收入社区集中贫困塑造了健康食品与适当医疗可及性受限的环境,最终导致这些人群糖尿病负担不成比例地加重。
- 种族与民族少数化群体实现血糖目标、获得新型降糖药物和/或获取糖尿病技术的能力更低。
- 下游效应是该人群因并发症(截肢、失明、终末期肾病)和死亡经历更差的健康结局。
临床怎么用
- 关注健康社会决定因素与结构性种族主义对糖尿病筛查、血糖控制、并发症与死亡的影响。
- 针对识别出的干预机会,推动循证诊疗的公平可及。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Inequities in diabetes diagnosis, management, and outcomes are deeply rooted in social determinants of health and structural racism. Historical policies such as redlining and concentrated poverty in low-income neighborhoods have shaped environments characterized by limited access to healthy food and proper healthcare, which ultimately led to a disproportionate burden of diabetes in these populations. The consequences of these disparities for racial and ethnic minoritized groups include a lower ability to achieve glycemic targets, receive novel glucose-lowering agents, and/or have access to diabetes technology. The downstream effect is that this population experiences worse health outcomes from complications (i.e., amputation, blindness, end-stage renal disease) and mortality. This narrative review synthesizes current literature on racial/ethnic inequities in diabetes care, highlighting differences in screening, glycemic control, complication rates, and mortality in people living with diabetes from diverse racial and ethnic backgrounds, but also identifies opportunities for intervention to ensure equitable access to evidence-based care.
引用
- Mazhude T, Lopez Fanas R, Myers AK, et al. Racial/ethnic inequities in diabetes mellitus: a narrative review. J Clin Endocrinol Metab. 2026. PMID: 42460782. doi:10.1210/clinem/dgag277
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。